Literature DB >> 19882711

Premature mortality due to cancer in Japan, 1995 and 2005.

Truong-Minh Pham1, Yoshihisa Fujino, Shinya Matsuda, Takesumi Yoshimura.   

Abstract

To better understand premature mortality due to cancer, we estimated years of life lost (YLL) and average years of life lost (AYLL) due to cancer for the years 1995 and 2005, based on data from the Vital Statistic of Japan. In men, we identified a total of 159,623 cancer deaths in 1995 and 196,603 in 2005. Total YLL were 2,342,560.4 and 2,724,066.0 years, respectively. Averaged for all cancers, people died 14.7 years earlier than life expectancy in 1995 and 13.9 years in 2005. AYLL was longest for brain cancer deaths, at 26.3 years earlier than expected in 1995 and 22.8 years in 2005, followed by leukemia. In women, a total of 103,399 cancer deaths occurred in 1995 and 129,338 in 2005. Total YLL were 1,818,960.4 years in 1995 and 2,160,706.5 years in 2005, corresponding to AYLL for all cancer combined of 17.6 and 16.7 years. The AYLL of brain cancer deaths was also the longest, at 29.4 years in 1995 and 27.8 in 2005, followed by leukemia and female sex-related cancers. Results showed that cancer of the stomach, colorectum, liver and lung were the most frequent cancers in both sexes in both 1995 and 2005 and responsible for a remarkable number of YLL. Further, AYLL was greatest for brain cancer and leukemia in both sexes and for sex-related cancers in women, namely breast, cervix and ovarian cancer.

Entities:  

Mesh:

Year:  2010        PMID: 19882711     DOI: 10.1002/ijc.25021

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

Review 1.  Incorporation of biomarkers in phase II studies of recurrent glioblastoma.

Authors:  Toni Rose Jue; Elizabeth Hovey; Sara Davis; Oliver Carleton; Kerrie L McDonald
Journal:  Tumour Biol       Date:  2014-12-23

2.  Colorectal cancer mortality in Inner Mongolia between 2008 and 2012.

Authors:  Ke-Peng Xin; Mao-Lin Du; Zhi-Yue Liu; Wen-Rui Wang; Yong-Gang Qian; Li Liu; Yun-Fei Lv; Juan Sun
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

3.  Leukemia-Related Mortality in Inner Mongolia, 2008-2012.

Authors:  Zhihui Hao; Yongsheng Chen; Yongjun Xu; Maolin Du; Ying Wang; Qing Zhang; Heixiao Bai; Sun Juan
Journal:  Glob J Health Sci       Date:  2015-11-18

4.  Focusing on the premature death of redeployed miners in China: an analysis of cause-of-death information from non-communicable diseases.

Authors:  Wei Xian; Bing Han; Leizhen Xia; Yining Ma; Haodi Xu; Lu Zhang; Li Li; Hongbo Liu
Journal:  Global Health       Date:  2019-01-22       Impact factor: 4.185

5.  IDO Inhibitor and Gallic Acid Cross-Linked Small Molecule Drug Synergistic Treatment of Melanoma.

Authors:  Hongmei Liu; Huan Gao; Cheng Chen; Wenyu Jia; Delong Xu; Guan Jiang
Journal:  Front Oncol       Date:  2022-07-01       Impact factor: 5.738

6.  Steroid sulphatase and oestrogen sulphotransferase in human non-small-cell lung carcinoma.

Authors:  S Iida; H Kakinuma; Y Miki; K Abe; M Sakurai; S Suzuki; H Niikawa; J Akahira; T Suzuki; H Sasano
Journal:  Br J Cancer       Date:  2013-03-26       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.